18883-66-4CN(N=O)C(=O)NC(C=O)C(O)C(O)C(O)COAGRCPNMCOXLKFO-UHFFFAOYSA-NSee also: Streptozocin (annotation moved to).
18883-66-4안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
개요Streptozotocin (STZ) was originally identified in the late 1950s as an antibiotic and was discovered in a strain of the soil microbe Streptomyces achromogenes. In the mid-1960s, STZ was found to be selectively toxic to the beta cells of the pancreatic islets and thus it is used in animal model of diabetes and as a medical treatment for cancers of the beta cells. STZ’s use in cancer chemotherapy received Food and Drug Administration approval in July 1982 and the drug was subsequently marketed as Zanosar.
용도Streptozotocin is used in the treatment metastatic cancer of the pancreatic islet cells. Streptozotocin has a highlrisk of toxicity and is generally limited to cancers that are inoperable.
일반 설명Off-white powder. Melting point 115°C. Used as an anti-cancer drug. Carcinogenic.
현재 필터 조건에 해당하는 반응 기록이 없습니다.
불러오는 중…
off-white to pale yellow crystalline powder
정의ChEBI: An antibiotic that is produced by Streptomyces achromogenes. It is used as an antineoplastic agent and to induce diabetes in experimental animals.